Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation

Bone Marrow Transplantation

Volumn 21, Issue 11, 1998, Pages 1125-1130

  Matute Bello, G ^a   McDonald, G D ^a,b   Hinds, M S ^b   Schoch, H G ^b   Crawford, S W ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplantation; Diffusing capacity; Hepatic veno occlusive disease; Pulmonary function tests; Risk factors

Indexed keywords

ACICLOVIR; CARBON MONOXIDE; HEMOGLOBIN; VANCOMYCIN;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DAMAGE; DISEASE SEVERITY; ENDOTHELIUM CELL; HUMAN; LIVER INJURY; LIVER VEIN OBSTRUCTION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESPIRATORY FAILURE; RISK FACTOR; TOTAL LUNG CAPACITY;

EID: 0031833915     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701225     Document Type: Article

References (29)

1. Springmeyer SC, Silvestri RC, Flournoy N et al. Pulmonary function of marrow transplant patients: I. Effects of marrow infusion, acute graft-versus-host-disease, and interstitial pneumonitis. Exp Hematol 1984; 12: 805-810.
2. Link H, Reinhard U, Blaurock M, Ostendorf P. Lung function changes after allogeneic bone marrow transplantation. Thorax 1986; 41: 508-512.
3. Prince DS, Wingard JR, Saral R et al. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 1989; 96: 301-306.
4. Badier M, Guillot C, Delpierre S et al. Pulmonary function changes 100 days and 1 year after bone marrow transplantation. Bone Marrow Transplant 1993; 12: 457-461.
5. Ghalie R, Szidon JP, Thompson L et al. Evaluation of pulmonary complications after bone marrow transplantation: the role of pretransplant function tests. Bone Marrow Transplant 1992; 10: 359-365.
6. Carlson K, Backlund L, Smedmyr B et al. Pulmonary function and complications subsequent to autologous bone marrow transplantation. Bone Marrow Transplant 1994; 14: 805-811.
7. Horak DA, Schmidt GM, Zaia JA et al. Pretransplant pulmonary function predicts cytomegalovirus associated interstitial pneumonia following bone marrow transplantation. Chest 1992; 102: 1484-1490.
8. Clark JC, Schwanz DA, Flournoy N et al. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med 1987; 66: 327-340.
9. Crawford SW, Fisher L. Predictive value of pulmonary function tests before marrow transplantation. Chest 1992; 101: 1257-1264.
10. Baudin B, D'Agay MF, Gluckman E. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res 1991; 63: 509-519.
11. Bazarbachi A, Scrobohaci ML, Gisselbrecth C et al. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease. Nouv Rev Fr Hematol 1993; 35: 135-140.
12. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
13. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1992; 144: 1202-1218.
14. Goldman HI, Becklake MR. Respiratory function tests. Normal values at median altitudes and the prediction of normal results. Am Rev Tubercul 1958; 79: 457-467.
15. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission. A randomized trial of two irradiation regimens. Blood 1990; 76: 1867-1871.
16. Clift RA, Buckner CD, Appelbaum FR et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens. Blood 1991; 77: 1660-1665.
17. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclos- porine compared with cyclosporine alone for prophylaxis of acute graft-versus-host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
18. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 832-843 and 895-902.
19. Thomas ED, Storb R. Techniques for human marrow grafting. Blood 1970; 36: 507-515.
20. Storb R, Thomas ED. Allogeneic bone marrow transplantation. Immunol Rev 1983; 71: 77-102.
21. Sullivan KM, Storb R, Allogeneic marrow transplantation. Cancer Invest 1984; 2: 27-38.
22. Hughes WT, Rivera GK, Schell MJ et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. New Engl J Med 1987; 316: 1627-1632.
23. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
24. Carreras E, Granena A, Rozman C. Hepatic veno-occlusive disease after bone marrow transplant. Blood Rev 1993; 7: 43-51.
25. Collins P, Roderick A, O'Brien D et al. Factor Vila and other haemostatic variables following bone marrow transplantation. Thromb Haemost 1994; 72: 28-32.
26. Baglin TP. Veno-occlusive disease of the liver complicating bone marrow transplantation. Bone Marrow Transplant 1994; 13: 1-4.
27. Krowka MJ, Statts BA, Hoagland HC. A prospective study of airway reactivity before bone marrow transplantation. Mayo Clin Proc 1990; 65: 5-12.
28. Anscher MS, Peters WP, Reisenbichler H et al. Transforming growth factor-beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. New Engl J Med 1993; 328: 1592-1598.
29. Scrobohaci ML, Drouet L, Monem-Mansi A et al. Liver venoocclusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res 1991; 63: 509-519.